Publication | Closed Access

Voriconazole as a first-line treatment against potentially pathogenic Acanthamoeba strains from Peru

Medical MicrobiologyPathogenic Acanthamoeba StrainsHealth SciencesFirst-line TreatmentAntimicrobial ChemotherapyMicrobiologyInfection ControlMedicineClinical MicrobiologyAntimicrobial ResistanceDrug Resistance